Prima BioMed remains with Australia

Prima BioMed, the Australian cancer therapy company has no immediate plans to delist from the Australian stock exchange, The Australian reported. Read below for a short clipping of the article: Questions have been raised recently about the depth of Australia’s investment pool for biotechnology companies after Biota last month revealed plans to delist its Australian shares and merge with Nasdaq-listed …